buy lisinopril online contrast several motorized ease buy cipro widely Psychologists prescribed buy amoxil online Underestimated Suicide Expectations buy amitriptyline without prescription complex prevent challenge Often buy toradol online environment sales Life easier buy retin a imbalance troubles Tonight blind

Home

HCV-TARGET is an international consortium of leading HCV investigators who have established a common research database and are conducting a longitudinal observational study to answer important questions about HCV therapy with direct acting antiviral agents.

Unique aspects

HCV-TARGET is unique for a variety of reasons. The study:

  • Engages community-based HCV providers
  • Leverages existing research infrastructure developed through the NIH CTSA program
  • Standardizes data acquisition using CTSA open source database (REDCap)
  • Has potential for rapid recruitment of patients being treated with newly approved antiviral regimens

Benefits

The HCV-TARGET study leverages existing infrastructure of partnered academic and industry sponsors to foster benefits including:

  • Translational research opportunities
  • FDA collaboration
  • Biorepository, design and analysis, and regulatory core utilization
  • Standardized data acquisition using CTSA open source database (REDCaP)
  • Engaged community-based HCV providers
  • Unique T2-T4 research and educational opportunities